Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
"We saw really very impressive response rates in these patients. These are patients, whose cancers had grown despite a great deal of previous treatment, including platinum-based chemotherapy for many. Under those circumstances, we'd expect that the average response rate to chemotherapy alone might be as low as single digits figures and the average survival would be somewhere between three to four months.
In our Phase I/II study we show this had been prolonged to an average of seven months, albeit not in a randomized trial. Based on the results of this study we've now started recruiting patients with advanced head and neck cancer to a randomized Phase III trial, in which all patients will receive chemotherapy and half will receive Reolysin as well. We are extremely excited about this progress."
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
Visit our Cancer / Oncology category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Rattue, Petra. "Head And Neck Cancer Chemotherapy Efficacy Boosted By Human Virus." Medical News Today. MediLexicon, Intl., 3 Apr. 2012. Web.
5 Dec. 2013. <http://www.medicalnewstoday.com/articles/243684>
Rattue, P. (2012, April 3). "Head And Neck Cancer Chemotherapy Efficacy Boosted By Human Virus." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/243684.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.